Citadel Advisors’s Coeptis Therapeutics COEP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,567
| Closed | -$20K | – | 6088 |
|
|
2024
Q3 | $20K | Buy |
+5,567
| New | +$20K | ﹤0.01% | 5336 |
|
|
2024
Q1 | – | Sell |
-1,136
| Closed | -$17.8K | – | 6187 |
|
|
2023
Q4 | $17.8K | Buy |
+1,136
| New | +$17.8K | ﹤0.01% | 5405 |
|
|
2022
Q4 | – | Sell |
-3,082
| Closed | -$627K | – | 6129 |
|
|
2022
Q3 | $627K | Sell |
3,082
-12
| -0.4% | -$2.44K | ﹤0.01% | 3861 |
|
|
2022
Q2 | $624K | Buy |
3,094
+188
| +6% | +$37.9K | ﹤0.01% | 3922 |
|
|
2022
Q1 | $587K | Buy |
2,906
+74
| +3% | +$14.9K | ﹤0.01% | 4283 |
|
|
2021
Q4 | $566K | Sell |
2,832
-29,718
| -91% | -$5.94M | ﹤0.01% | 4456 |
|
|
2021
Q3 | $6.48M | Sell |
32,550
-450
| -1% | -$89.5K | ﹤0.01% | 1825 |
|
|
2021
Q2 | $6.5M | Sell |
33,000
-70
| -0.2% | -$13.8K | ﹤0.01% | 1857 |
|
|
2021
Q1 | $6.49M | Buy |
+33,070
| New | +$6.49M | ﹤0.01% | 1820 |
|